1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Amphastar Pharmaceuticals Inc (AMPH) Files 10-K for the Fiscal Year Ended on December 31, 2017

March 14, 2018 | About:

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings. Amphastar Pharmaceuticals Inc has a market cap of $935.606 million; its shares were traded at around $20.35 with a P/E ratio of 226.11 and P/S ratio of 4.08.

For the last quarter Amphastar Pharmaceuticals Inc reported a revenue of $60.4 million, compared with the revenue of $63.54 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $240.2 million, a decrease of 5.9% from the previous year. For the last five years Amphastar Pharmaceuticals Inc had an average revenue growth rate of 3.8% a year.

The reported diluted earnings per share was 9 cents for the year, a decline of 59.1% from the previous year. The Amphastar Pharmaceuticals Inc had an operating margin of -0.37%, compared with the operating margin of 6.15% a year before. The 10-year historical median operating margin of Amphastar Pharmaceuticals Inc is 1.71%. The profitability rank of the company is 5 (out of 10).

At the current stock price of $20.35, Amphastar Pharmaceuticals Inc is traded at 41.1% premium to its historical median P/S valuation band of $14.42. The P/S ratio of the stock is 4.08, while the historical median P/S ratio is 2.89. The stock gained 38.06% during the past 12 months.

For the complete 20-year historical financial data of AMPH, click here.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

dxpakRare Finds
simpsonjd4Below Book Insider
simpsonjd4Net Net Clone
simpsonjd4Neg EV/EBIT
DBrizanALL 18Mar2018 1140p
DBrizanALL 18Mar2018 746p
pbarker46Good yield, reasonable PS
DBrizanALL 18Mar2018 623p
DBrizanALL 18Mar2018 622p
DBrizanALL 18Mar2018 609p
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat